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ASSESSMENT OF SELF-EXTRACTED CELLULOSE FROM ORYZA SATIVA FOR DESIGN OF 
CONTROLLED DRUG DELIVERY SYSTEM OF DALFAMPRIDINE
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Objectives: The main objective of the present work includes extraction of cellulose from Oryza sativa (OS), characterization of cellulose, development 
of controlled release tablet dalfampridine using cellulose of OS, and in vitro evaluation.
Methods: Dry powdered OS husk sample was extracted with a mixture of hexane and methanol (2:1, v/v) using soxhlation method and was 
characterized by solubility, melting point determination, differential scanning calorimetry (DSC), and Fourier-transform infrared (FTIR) analysis. 
Compatibility between dalfampridine and the mixture of cellulose with dalfampridine was confirmed by FTIR and DSC analysis. Then, controlled drug 
delivery system of dalfampridine were prepared as directly compressed tablets using various compositions containing OS cellulose, hydroxypropyl 
methylcellulose (HPMC), dicalcium phosphate, and magnesium stearate (8 nos. F1 to f8) and were evaluated.
Results: Cellulose was extracted from OS extract to possess its ideal characteristics. Dalfampridine and its mixture with cellulose were compatible 
according to FTIR and DSC analysis. Directly compressed tablets made with 10 mg of dalfampridine and OS cellulose, HPMC, dicalcium phosphate, and 
magnesium stearate evidenced prolonged and controlled drug delivery of dalfampridine for 12 h. Formulation made with OS cellulose 250 mg, HPMC 
20 mg, dicalcium phosphate 40 mg, and magnesium stearate 5 mg was ideal without burst release.
Conclusion: Cellulose extracted from OS is used successfully for the production of directly compressed tablets of dalfampridine to elicit optimum 
characteristics including controlled drug delivery for 12 h.
Keywords: Cellulose from Oryza sativa, Soxhlation method, Fourier-transform infrared, Compatibility, Dalfampridine, Controlled delivery.
INTRODUCTION
Synthetic polymers and celluloses are generally utilized for the design 
of controlled or novel drug delivery systems. There are chances of toxic 
effects produced from synthetic polymers or celluloses. At this juncture, 
natural polymers reported with less toxicity and high biodegradability 
can be taken as a choice for the design of formulations of drugs. Cellulose 
is one of the polymers used in biomedical applications. It was reported 
that all-cellulose composites possess an intriguing combination of high 
strength and biodegradability [1].
OS (RH) is one of the major agricultural residues generated as a by-
product during the rice milling process. According to Jackson, OS 
consists of 33% cellulose, 26% hemicellulose, and 7% lignin. Cellulose 
is a polysaccharide made of d-glucose connected through -1,4-glycosidic 
bonds and is a promising raw material for producing important 
chemicals, including cellulosic ethanol, hydrocarbons, and starting 
materials to produce polymers [2].
At present, the model drug selected is dalfampridine which is recently 
approved by the FDA in January 2010 for symptomatic treatment of MS 
patients with a specific indication for improvement in walking. In the 
past, 4-aminopyridine has been used as an experimental agent which 
presumably enhances nerve conduction of demyelinated axons through 
its effects on potassium channels for the treatment of fatigue in MS. 
Moreover, now, dalfampridine is used successfully. Hence, it is aimed to 
design in the form of controlled-release tablets.
The work involves four objectives such as extraction of cellulose from 
OS, characterization of cellulose, development of controlled release 
tablet dalfampridine, and in vitro evaluation.
MATERIALS AND METHODS
Methods
Isolation of cellulose from OS
Dry powdered OS husk sample was extracted with a mixture of hexane 
and methanol (2:1, v/v) using soxhlation method for 10 h for removal 
of oil/wax, etc. Then, the delignification is done a follow-up with using 
two-step processes usually. At first, the extractive-free OS husk (10 g) 
was soaked in 300 ml different alkalis (5%, w/v) with a ratio of liquor 
to the material (30:1) and heated to 80°C for 5 h. Then, the collected 
slurry can cool. Then, it is treated with 10% H2SO4 to neutralize the 
solution. Then, it adjusts to 3–4 of pH value at 50°C [3,4].
After extraction, residual biomass was separated by filtration through 
Buchner funnel connected to a vacuum pump. The residual biomass 
was undertaken for bleaching treatment using 2% H2O2 solution with 
adjusting pH value 9 and the ratio of liquor to the materials (30:1) and 
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  ABSTRACT
Therefore,  in  the  present  research  work,  we  have  exploited 
cellulose from Oryza sativa (OS) for the design of drug for the 
treatment of multiple sclerosis (MS) as there are no reports for 
utilization  of  this  cellulose  in  the  development  of  drug  delivery 
systems.  Formulations.
hydroxypropyl methylcellulose (HPMC), dicalcium phosphate, and 
magnesium stearate were purchased from SD Fine Chemicals Ltd.
Materials
Dalfampridine was purchased from Simpson Pharmacy,  Mumbai. 
n-Hexane, methanol, hydrogen peroxide, liquid nitrogen, KBr, 
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stirred for 5 h at room temperature [5]. Then, the biomass was cleaned 
with distilled water specifically for many times to attain chemical 
free product including H2O2. The collected samples were filtered and, 
in an oven, sieved through 40 mesh screen and stored in the airtight 
container to prevent oxidation for the future use.
Characterization of cellulose
Extracted cellulose was characterized by solubility, melting point 
determination, differential scanning calorimetry (DSC), and Fourier-
transform infrared (FTIR) analysis.
Solubility of cellulose
Solubility:
As cellulose is insoluble in water, a freshly prepared solvent system 
(NaOH/H2O) pre-cooled to −1°C was tried test solubility [7]. The 
solution was kept in a freezer at 0ºC. Then, the cellulose was added 
to the solvent in a cooled container refrigerated through circulation 
of a water-polyethylene glycol solution. Each solution was stirred for 
20 min at 500 rpm. The temperature was kept at −1°C during the first 
couple of minutes and then increased to +4°C.
Melting point
Melting point of prepared cellulose was determined by open capillary 
tube method [6]. The capillary tube was closed at one end by fusion 
and was filled with the drug on the other end by repeated tapings. The 
capillary tube was placed on apparatus. The instrument was set to 
automatically increase the temperature of the heating bath at a rate of 
1°C per minute. The temperature at which the drug started melting is 
recorded. This was performed thrice, and their average was taken as a 
result.
DSC
DSC analysis was carried out for the cellulose of OS using DSC (Mettler, 
Toledo, Switzerland) and scanned for a range of 10°C/min under static 
air atmosphere.
FTIR
FTIR spectrum of extracted cellulose was obtained using IR 
spectrophotometer (Bruker, JAPAN) by KBr pressed pellet technique. 
The scanning range was 4000–400 cm−1 and the resolution was 1 cm−1.
Drug-excipient interaction study of dalfampridine with cellulose 
of OS
As the present work was to develop controlled drug delivery system 
of dalfampridine using the self-extracted cellulose of OS, drug-
Table 1: Composition of dalfampridine controlled-release tablets
Ingredients (mg) F1 F2 F3 F4 F5 F6 F7 F8
Dalfampridine 10 10 10 10 10 10 10 10
RH cellulose 150 125 200 200 _ 250 300 _
HPMC 29 89 30 _ 105 20 _ 120
Dicalcium phosphate 131 106 80 110 205 40 10 190
Magnesium stearate 5 5 5 5 5 5 5 5
Total 325 325 325 325 325 325 325 325
Fig. 2: Differential scanning calorimetry of Oryza sativa cellulose
Fig. 1: The alkali (liquid ammonia)-treated Oryza sativa cellulose Fourier-transform infrared
Pretreatment of cellulose: Ethanol acid pre-treatment
In a water bath, add several liters of cold distilled water to 
remove  unnecessary  chemicals  and  for  cooling.  Ethanol  was 
pre-heated  to  60°C.  Then,  when  thermal  equilibration  was  reached, 
hydrochloric acid (37wt.%) was added. 16 g of cellulose pulp was 
added  to  ensure  homogeneous  dispersion  of  the  cellulose  in  the 
ethanol-acid  medium,  especially  under  continuous  stirring  that  the 
performed  reaction  was  stopped  after  30  min.  Then,  to  remove  any 
residuals of ethanol and HCl completely, the collected biomass was filtered
 and washed with distilled water [6].
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excipient interaction studies were carried out to assess compatibility 
between them. Hence, DSC thermogram and FTIR spectrum were 
taken for the mixture of dalfampridine and cellulose of OS and were 
compared.
Evaluation of pre-compression characteristics
Pre-compression parameters such as angle of repose, bulk density, and 
tapped density were determined for the blend of all the formulations 
to assess free flow characteristics [6]. Then, the prepared compressed 
tablets were evaluated by different tests.
The angle of repose
The angle of repose “θ” is determined by fixed funnel and free-standing 
cone method using the following equation:
θ = tan-1 (h/r)
Where θ = angle of repose, h=height of the pile, and r = radius of the pile.
Carr’s compressibility index and Hausner’s Ratio
Bulk density was measured by filling the powder in measuring 
cylinder and the tapped density was determined by tapping 
method [6]. Compressibility index and Hausner’s ratio are calculated 
using the following equations:







’   =
Table 2: Oryza sativa cellulose functional group identification




OH Stretching 3990 3386
C=O Stitching 1751 1896
C-H Bending 1369 1315.84
C-O Stretching 1220 1236.89
C-O-C Pyranose ring 1384 1388.47
β-glycoside linkage 910 858.35
O-H Bending 1384 1388.47
Fig. 3: Differential scanning calorimetry of dalfampridine
Fig. 4: Differential scanning calorimetry of Oryza sativa cellulose 
and dalfampridine
Table 3: IR absorption peaks of pure dalfampridine and its 
mixture with Oryza sativa cellulose









As all powder blends of all formulations evidenced good flow properties, 
tablets were compressed for all F1–F8.
Evaluation of compressed tablets
The compressed tablets were evaluated by thickness, hardness, 
friability, drug content uniformity, and in vitro drug release studies.
Thickness was determined by Vernier caliper. Hardness was tested 
using Monsanto hardness tester, and friability test was carried out 
using Roche Friability Apparatus (Veego Instruments Ltd., India).
Drug content uniformity
Drug content estimation was carried out by collecting ten tablets from 
each batch at random [8]. The tablets were powdered, and the fine powder 
(equivalent to 10 mg of dalfampridine) was transferred to a 100 ml 
volumetric flask and dissolved in water. The solutions were made up to the 
volume, filtered, and suitably diluted, and drug contents were estimated 
using UV-visible spectrophotometer (Systronics, India) at 262 nm.
Disintegration test
The disintegration time of tablets was determined for 6 tablets using 
Thermionic Tablet Disintegration Test Apparatus [8]. pH 7.4 phosphate 
buffer maintained at 37±0.5°C in isothermal water bath was used as a 
medium.
In vitro drug release studies of prepared tablets
In vitro dissolution release studies were carried out for the prepared 
tablets of flutamide and glimepiride in comparison with the commercial 
Preparation of dalfampridine tablets
Controlled release tablets containing 10 mg of dalfampridine 
were  prepared  using  self-extracted  OS  cellulose  by  direct 
compression  [6].  Eight  formulations,  F1–F8,  were  tried  and  their 
composition  is  given  in  Table  1.  The  ingredients  necessary  for  the 
preparation  of  100  were  accurately  weighed  and  mixed  in  a 
polyethylene  bag.  Then,  the  material  was  sieved  through  #40  and 
determined  for  micromeritic  properties.  Lubricated  blend  was  then 
compressed into tablets using oval-shaped B tooling punches using 13 KP
 pressure  to  get  325  mg  in  10  station  rotary  compression  machine 
(Rimek, Mumbai).
Hausner’s ratio is calculated as the simple difference between 
the tapped density and bulk density.
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Fig.5:  Fourier-transform infrared  of dalfampridine
tablets of both the drugs [9]. The test was carried out using USP XXI 
Dissolution Testing Apparatus Type II, (Electrolab, India) using 900 ml 
of pH 6.8 phosphate buffer maintained at 37±0.5°C as medium. Stirring 
speed was maintained at 50 rpm. Aliquot samples were withdrawn at 













F1 0.80±0.13 0.942±0.2 15.07±1.2 1.14±0.01 25.12±0.94
F2 0.78±1.0 0.931±0.6 16.21±0.2 1.19±0.19 25.86±0.35
F3 0.81±0.7 0.932±0.1 13.09±0.3 1.15±0.32 25.21±0.58
F4 0.80±0.2 0.936±0.8 14.52±0.4 1.17±1.09 25.23±0.21
F5 0.78±0.9 0.925±0.5 15.06±0.7 1.18±0.07 25.21±0.98
F6 0.80±0.2 0.931±0.9 14.07±0.2 1.16±0.03 26.45±0.43
F7 0.82±0.3 0.928±0.1 11.63±0.6 1.13±0.05 26.23±0.74
F8 0.80±1.4 0.927±0.3 13.70±0.3 1.15±0.08 25.88±0.97
Table 5: Evaluation parameters of formulation, F1–F8 (n=3±SD)
Formulation
Code










F1 7.94±0.12 0.405±0.40 4.231±0.01 7±0.3 87±0.02
F2 7.84±0.86 0.405±0.40 4.233±0.01 6.56±0.2 90±0.05
F3 8.01±0.14 0.420±0.07 4.248±0.02 6.48±0.2 94±0.09
F4 6.10±0.11 0.012±0.10 4.244±0.01 7.52±0.3 95±0.03
F5 7.41±0.14 0.015±0.01 4.256±0.02 7.45±0.3 97±0.06
F6 8.14±0.29 0.007±0.06 4.246±0.01 7.80±0.1 96±0.07
F7 4.25±0.10 0.422±0.52 4.234±0.01 8.50±0.1 94±0.02
F8 5.10±0.05 0.006±0.04 4.248±0.01 8.41±0.3 92±0.07
Fig. 6: The alkali (liquid ammonia)-treated Oryza sativa cellulose Fourier-transform infrared
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Table 7: Model independent and dependent parameters of dissolution data
Formulation code Zero-order R2 value First-order R2 value Higuchi R2 value Korsmeyer
R2 N
F1 0.964 0.905 0.932 0.739 1.36
F2 0.862 0.771 0.830 0.463 1.31
F3 0.812 0.918 0.880 0.417 1.43
F4 0.943 0.811 0.909 0.657 1.38
F5 0.935 0.804 0.879 0.694 1.43
F6 0.925 0.824 0.960 0.752 1.28
F7 0.918 0.876 0.872 0.614 1.36
F8 0.989 0.886 0.970 0.848 1.40 
Table 6: Dissolution profiles of formulations, F1–F8
Time (h) % Cumulative Drug Release (n=3 ± SD)
F1 F2 F3 F4 F5 F6 F7 F8
30 min 19±0.1 10±0.3 12±0.1 18±0.3 23±0.2 15±0.3 17±0.1 24±0.2
45 min 23±0.2 22±0.2 29±0.1 26±0.2 26±0.1 21±0.3 22±0.1 29±0.1
1 34±0.1 38±0.2 43±0.1 36±1.2 38±0.1 29±0.7 36±0.1 32±0.1
2 38±1.2 38±0.5 55±0.4 40±1.4 40±0.3 29±1.2 36±0.2 38±0.7
3 38±0.3 44±0.8 60±0.8 43±0.8 46±0.4 35±0.2 38±0.3 40±1.2
4 40±0.3 45±0.7 61±0.6 46±0.9 46±0.8 56±0.3 38±0.1 45±0.8
5 46±0.7 45±0.1 63±0.7 48±0.6 46±0.7 63±0.2 40±0.3 56±2.1
6 55±0.6 48±0.1 64±1.2 48±0.1 46±0.1 69±0.5 46±0.8 64±0.8
7 68±1.2 48±0.4 66±1.4 55±0.2 54±0.1 70±0.7 50±0.7 66±0.6
8 76±0.9 51±0.3 70±0.6 66±0.3 65±0.2 74±0.3 55±0.6 70±0.4
9 88±1.2 66±0.3 74±0.8 77±0.3 78±0.3 74±0.3 68±1.2 72±0.2
10 90±1.4 82±0.7 86±1.2 79±0.6 80±0.7 74±0.4 78±1.4 84±0.1
11 95±1.3 89±0.8 88±1.3 85±0.8 85±0.3 87±0.4 78±1.2 88±0.1
12 95±0.1 94±0.2 90±0.1 94±0.1 94±0.2 96±0.5 83±0.8 95±0.2
pre-determined time intervals and filtered through 0.45 µm Millipore 
filter, suitably diluted wherever necessary, and were analyzed for the 
drug content by UV-visible spectrophotometer (Systronics, India). 
The volume withdrawn at each time interval was replaced with fresh 
dissolution medium maintained at the same temperature. Each study 
was performed in triplicate and mean values are reported.
Assessment of release kinetics of dalfampridine tablets
Rate and mechanism of drug release from matrix tablets were assessed 
by fitting the data into zero order kinetics (Q=Ko t), first-order kinetics 
(log Q=Log Q0+K1t/2.303), Higuchi’s model (Q=KH t½), and Korsmeyer–




Prepared cellulose from OSO was completely soluble in a selected 
solvent system (NaOH/H2O) pre-cooled to −1°C. This supported the 
solubility characteristics of celluloses reported in literature [7].
FTIR
FTIR spectrum of OS cellulose is shown in Fig. 1. The absorption peaks 
are shown in Table 2. As revealed, OH- stretching is at 3386, C=O 
stretching was observed at 1896, CH-bending was observed at 1315.84, 
C-O stretching was observed at 1236.89, C-O-C Pyranose ring was 
observed at 1388.47, and β-glycoside linkage was observed at 888.36. 
All these values are coinciding with the values of those groups reported 
for cellulose in the literature [11,3].
Melting point
Melting point observed for the cellulose of OS is 456°C the value which 
is closer to value reported in literature (467°C) [12].
DSC of OS cellulose
DSC thermogram of cellulose of OS is presented in Fig. 2. It is observed 
that the melting point is present at 316.83°C. This value is coinciding 
with the reported range of melting point (315–400°C) for cellulose 
materials. Hence, it is concluded that the extraction procedure utilized 
in the present work is suitable to produce cellulose with optimum 
characteristics to be used in drug development.
Drug-excipient interaction study of dalfampridine with cellulose of OS
DSC thermogram of dalfampridine as presented in Fig. 3 showed a 
melting peak at 164.80°C, whereas its mixture with dalfampridine with 
cellulose showed melting peak at 167°C (Fig. 4). This slight modification 
is ignored and cosidered as incopamatibility.
The FTIR spectrum of dalfampridine and its mixture with cellulose 
and drug is shown in Fig. 5 and Fig. 6, respectively. Absorption peaks 
of both are shown in Table 3 for easy comparison. Dalfampridine 
peaks, NH-stretch at 3437.37, CH-stretch (aromatic) at 3031.66, 
C=N bond at 1648.46, C=C bond 1504.49, and CH-bending at 
1433.83 are not modified appreciably in Fig. 6. Hence, it is 
considered that there is no incompatibility dalfampridine and OS 
cellulose mixture [13].
After assessing compatibility between dalfampridine and cellulose of OS, 
directly compressed tablets of dalfampridine were prepared (8 nos. F1 to F8).
Before compression, pre-compression parameters of blends were 
assessed and are shown in Table 4. Compressibility index and Hausner’s 
ratio were in the range of 11.63%–16.21% and 1.13–1.19, respectively. 
The angle of repose between 25.12±0.94 and 26.45±0.43 indicted good 
flow properties of all prepared formulations, F1–F8.
Hence, all formulations were compressed directly and evaluated. 
Results of various parameters of F1 to F8 are given in Table 5. Post-
compression parameters of prepared directly compressed tablet 
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Fig. 7: Percentage drug release profiles of formulations, F1–F4
Fig. 8: Percentage drug release profiles of formulations, F5–F8
Fig. 9: Zero order for F1–F3
In vitro drug release studies of prepared tablets
In vitro drug release data as shown in Table 6 and Figs. 7 and 8 clearly 
indicate prolonged and controlled drug delivery of dalfampridine for 12 h. 
Fig. 10: Zero order for F4–F6
Fig. 11: Zero order for F7–F8
Fig. 12: First order for F1–F3
However, there is a ideal controlled release from F6 without exhibiting 
burst release (≥31%) [14] within 1 h. Hence, from these studies, F6 is 
considered as best formulation assessed for release kinetics.
formulations,  F1–F8,  of  dalfampridine  are  given  in  Table  14. 
Weight  variation  values  are  in  the  range  of  0.03–0.09%. 
Hardness is in between 5.10 and 8.14 kg/cm2. Thicknesses are 
from 4.231 mm to 4.256 mm. Friability is  in the acceptable 
values  of  0.007–0.422%.  Disintegration  time  obtained  is  in  a 
reasonable  range  of  6.48–8.50  min,  and  drug  content  is  in  87–97%. 
Hence,  these  results  indicated  that  all  the  parameters  of  prepared 
formulations, F1–F8, are in official limits.
Assessment of release kinetics of dalfampridine tablets
Zero  order,  first  order,  Higuchi,  and  Korsmeyer  plots  are 
shown in Figs. 9-20 and the corresponding “r” values are in given in 
Table  7. “r” values closer unity in case of zero-order and Higuchi plots 
indicate  that  the  release  kinetics  of  dalfampridine  from  prepared 
tablets is followed in zero-order and by mechanism of diffusion.
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Fig. 13: First order for F4–F6
Fig. 14: First order for F7 and F8
Fig. 15: Higuchi model for F1–F3
Fig. 16: Higuchi model for F4–F6
Fig. 17: Higuchi model for F7– F8
Fig. 18: Korsmeyer model for F1–F3
CONCLUSION
“Hence from these studies, it is concluded that cellulose of OS can be 
used successfully for the production of directly compressed tablets of 
dalfampridine to elicit optimum characteristics including controlled 
drug delivery for 12 h.”
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Fig. 20: Korsmeyer model for F7–F8
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